4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-25-000046
Options or other derivatives
- President and CEO acquired 140,103 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BLATT LAWRENCE · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-28 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +140,103 | 140,103 | D |
Loading xslF345X05/form4.xml…